Clinical Trial Update: Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum [Phase 3]

View source ↗

Summary

Phase 3 trial assessing antifolates for malaria in HIV-infected pregnant women and reporting emergence of induced resistance in Plasmodium falciparum.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Malaria in Pregnancy

Snippet

Sponsor: Institut Pasteur | Conditions: Malaria in Pregnancy, HIV Infection | Phase 3 | Status: COMPLETED